Search Results - Outi Kuittinen

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Significance of bulky mass and residual tumor—Treated with or without consolidative radiotherapy—To the risk of relapse in DLBCL patients by Susanna Tokola, Hanne Kuitunen, Taina Turpeenniemi‐Hujanen, Outi Kuittinen

    Published in Cancer Medicine (2020-03-01)
    Get full text
    Article


  2. 2

    Population based registry study on large B-cell lymphoma mortality and morbidity in Finland by Anna Anttalainen, Liisa Ukkola-Vuoti, Ville Vihervaara, Saija Silvola, Outi Kuittinen

    Published in Acta Oncologica (2025-02-01)
    Get full text
    Article


  3. 3

    FDG‐PET/CT‐guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma by Aino Rajamäki, Hanne Kuitunen, Marc Sorigue, Salla‐Maarit Kokkonen, Outi Kuittinen, Kaisa Sunela

    Published in Cancer Medicine (2023-01-01)
    Get full text
    Article


  4. 4

    Drug‐induced pneumonitis risk in diffuse large B‐cell/follicular lymphoma patients treated with R‐CHOP‐like regimen is associated with the use of granulocyte colony‐stimulating gro... by Elina Kaprio, Roosa Prusila, Susanna Tokola, Milla E. L. Kuusisto, Esa Jantunen, Hanne Kuitunen, Taina Turpeenniemi‐Hujanen, Outi Kuittinen

    Published in Cancer Medicine (2024-01-01)
    Get full text
    Article


  5. 5

    A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoin... by Satu Tiainen, Veera Nurmela, Tuomas Selander, Patrik Turunen, Sanna Pasonen-Seppänen, Tiia Kettunen, Outi Kuittinen, Päivi Auvinen, Aino Rönkä

    Published in BMC Cancer (2023-12-01)
    Get full text
    Article


  6. 6

    Vitamin C boosts DNA demethylation in TET2 germline mutation carriers by Aurora Taira, Kimmo Palin, Anna Kuosmanen, Niko Välimäki, Outi Kuittinen, Outi Kuismin, Eevi Kaasinen, Kristiina Rajamäki, Lauri A. Aaltonen

    Published in Clinical Epigenetics (2023-01-01)
    Get full text
    Article


  7. 7

    Outcome of lung cancer surgery and proportion of lung cancer patients eligible for surgery in five Finnish hospitals in 2018, real world study by Ville Paappanen, Jenny Tikka, Arja Jukkola, Tuula Klaavuniemi, Liisa Sailas, Maria Tengström, Hanne Kuitunen, Teemu Riekkinen, Satu Tiainen, Outi Kuittinen

    Published in Acta Oncologica (2025-07-01)
    Get full text
    Article


  8. 8

    Survival of patients with classical Hodgkin lymphoma in Finland: a national population-based analysis by Noora Hannuksela, Anu Partanen, Anna Anttalainen, Liisa Ukkola-Vuoti, Iiro Toppila, Johanna Vikkula, Katja Marin, Hanne Kuitunen, Tatu Miettinen, Outi Kuittinen, Aino Rönkä

    Published in Blood Cancer Journal (2024-08-01)
    Get full text
    Article


  9. 9

    Progression-free survival after front line, second line and third line in patients with follicular lymphoma treated in clinical practice by Aino Rajamaki, Marc Sorigue, Roosa E.I. Prusila, Milla E.L. Kuusisto, Hanne Kuitunen, Esa Jantunen, Santiago Mercadal, Taina Turpeenniemi-Hujanen, Juan-Manuel Sancho, Kaisa Sunela, Outi Kuittinen

    Published in Acta Oncologica (2024-05-01)
    Get full text
    Article


  10. 10

    Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: result... by Elisa J. Pulczynski, Outi Kuittinen, Martin Erlanson, Hans Hagberg, Alexander Fosså, Mikael Eriksson, Marie Nordstrøm, Bjørn Østenstad, Øystein Fluge, Sirpa Leppä, Bente Fiirgaard, Hanne Bersvendsen, Unn-Merete Fagerli

    Published in Haematologica (2015-04-01)
    Get full text
    Article


  11. 11

    Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria by Minna Harmanen, Tuula Klaavuniemi, Marc Sorigue, Madiha Khan, Roosa Prusila, Esa Kari, Erika Alanne, Aino Rajamäki, Kaisa Sunela, Arja Jukkola, Esa Jantunen, Juan-Manuel Sancho, Sanna Ketola, Hanne Kuitunen, Tuomas Selander, Aino Rönkä, Outi Kuittinen

    Published in HemaSphere (2023-10-01)
    Get full text
    Article


  12. 12

    Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up by Elisa Jacobsen Pulczynski, Mikkel Runason Simonsen, Outi Kuittinen, Unn-Merete Fagerli, Martin Erlanson, Øystein Fluge, Sirpa Leppä, Bjørn Østenstad, Alexander Fosså, Mikael Eriksson, Tarec El-Galaly, Hanne Kuitunen, Karin Papworth, Maria Ljungqvist, Martin B. Pedersen, Marjukka Pollari

    Published in Haematologica (2024-03-01)
    Get full text
    Article


  13. 13

    Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3 by Christian Winther Eskelund, Kostas Dimopoulos, Arne Kolstad, Ingrid Glimelius, Riikka Räty, Lise Mette Rahbek Gjerdrum, Kristina Sonnevi, Pär Josefsson, Herman Nilsson-Ehle, Hans H. N. Bentzen, Unn Merete Fagerli, Outi Kuittinen, Jacob Haaber, Carsten Utoft Niemann, Lone Bredo Pedersen, Maria Torp Larsen, Christian Hartmann Geisler, Martin Hutchings, Mats Jerkeman, Kirsten Grønbæk

    Published in HemaSphere (2021-01-01)
    Get full text
    Article


Search Tools: